ThinkingNode.Life

ThinkingNode.Life (TNL) is the first AI Digital Cells Factory for drug R&D using a proprietary process, called Digital Cell Differentiation. This allows TNL to generate digital human cell clones within an hour using gene expression data to predict and mechanistically understand the impacts of molecules or drugs on any human cells of interest. This impacts the entire drug R&D workflow in multiple ways. By being able to mechanistically identify novel disease-targets and to simulate each drug in various R&D phases, TNL provides a decisive advantage for developing both first-in-class and best-in-class drug. All this is possible based on the novel Generative Macro-connectionist Reasoning AI (GMR-AI) that employs Distributed Reasoning AI instead of statistical Machine Learning to generate causal reasoning models.

Khai Pham, MD & PhD (AI) (Sorbonne University), is the founder & CEO of TNL. He has been in the AI field for 30 years. He is the author of Macro-connectionist Reasoning AI, a unified Neuro-Symbolic AI approach that differs from Connectionism (regular Artificial Neural Networks) by considering assemblies of neurons rather than a single neuron. The first generation of his Distributed AI was used in his first AI company (acquired by Nasdaq: EPNY for $637M). At TNL, he is surrounded by a multi-disciplinary executive team that has been involved in $10B total exits.